Fused polycyclic heteroaromatic compound and organic thin film and electronic device

US11242357B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11242357-B2
Application numberUS-201816140661-A
CountryUS
Kind codeB2
Filing dateSep 25, 2018
Priority dateOct 18, 2017
Publication dateFeb 8, 2022
Grant dateFeb 8, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A fused polycyclic heteroaromatic compound represented by Chemical Formula 1, and an organic thin film, an organic thin film transistor, and an electronic device including the fused polycyclic heteroaromatic compound are provided. The fused polycyclic heteroaromatic compound may have a conjugation structure but reinforce planarity among adjacent rings and have further dense packing and thus much increase charge mobility.

First claim

Opening claim text (preview).

What is claimed is: 1. A fused polycyclic heteroaromatic compound represented by Chemical Formula 1: wherein, in Chemical Formula 1, X 1 and X 2 are independently O, S, Se, Te, or N—R a , wherein R a is hydrogen, a substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted C3 to C30 cycloalkyl group, a substituted or unsubstituted C6 to C30 aryl group, a substituted or unsubstituted C7 to C30 arylalkyl group, a substituted or unsubstituted C1 to C30 heteroalkyl group, a substituted or unsubstituted C2 to C30 heterocycloalkyl group, a substituted or unsubstituted C2 to C30 heterocyclic group, a substituted or unsubstituted C2 to C30 alkenyl group, a substituted or unsubstituted C2 to C30 alkynyl group, a hydroxy group, a halogen atom, or a combination thereof, Ar is a substituted or unsubstituted C6 to C30 aromatic ring, a substituted or unsubstituted C3 to C30 heteroaromatic ring, or a fused ring including the fused two or more rings, Ar is combined with an X 1 -containing hetero ring and an X 2 -containing hetero ring to provide a condensed polycyclic ring, R 1 and R 2 are independently hydrogen or a halogen atom, and R 3 and R 4 of Chemical Formula 1 are independently one of heterocyclic groups represented by Chemical Formula 2-1 and Chemical Formula 2-2: wherein, in Chemical Formula 2-1 and Chemical Formula 2-2, X 3 is S, Se, or Te, R 11 and R 12 are independently hydrogen, a substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted C3 to C30 cycloalkyl group, a substituted or unsubstituted C6 to C30 aryl group, a substituted or unsubstituted C7 to C30 arylalkyl group, a substituted or unsubstituted C1 to C30 heteroalkyl group, a substituted or unsubstituted C2 to C30 heterocycloalkyl group, a substituted or unsubstituted C2 to C30 heterocyclic group, a substituted or unsubstituted C2 to C30 alkenyl group, a substituted or unsubstituted C2 to C30 alkynyl group, a hydroxy group, a halogen atom, or a combination thereof, R 11 and R 12 are independently present alone or combined to provide a ring, R 13 and R 14 are hydrogen or are a substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted C3 to C30 cycloalkyl group, a substituted or unsubstituted C6 to C30 aryl group, a substituted or unsubstituted C7 to C30 arylalkyl group, a substituted or unsubstituted C1 to C30 heteroalkyl group, a substituted or unsubstituted C2 to C30 heterocycloalkyl group, a substituted or unsubstituted C2 to C30 heterocyclic group, a substituted or unsubstituted C2 to C30 alkenyl group, a substituted or unsubstituted C2 to C30 alkynyl group, a hydroxy group, or a combination thereof combined to provide a ring, R 15 is a halogen atom, and * is a linking point with the condensed polycyclic ring of Chemical Formula 1, and wherein the condensed polycyclic ring and the heterocyclic group represented by Chemical Formula 2-1 or Chemical Formula 2-2 are substantially present in the same plane. 2. The fused polycyclic heteroaromatic compound of claim 1 , wherein R 11 to R 14 are independently hydrogen. 3. The fused polycyclic heteroaromatic compound of claim 1 , wherein at least one of R 1 and R 2 is a halogen atom. 4. The fused polycyclic heteroaromatic compound of claim 1 , wherein Ar has four to eight rings. 5. The fused polycyclic heteroaromatic compound of claim 1 , wherein the condensed polycyclic ring is represented by one of Chemical Formula 3-1 to Chemical Formula 3-16: wherein, in Chemical Formula 3-1 to Chemical Formula 3-16, X 1 , X 2 , R 1 , R 2 , R 3 , and R 4 are the same as in Chemical Formula 1, X 11 to X 19 are independently O, S, Se, Te, or N—R a , wherein R a is hydrogen, a substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted C3 to C30 cycloalkyl group, a substituted or unsubstituted C6 to C30 aryl group, a substituted or unsubstituted C7 to C30 arylalkyl group, a substituted or unsubstituted C1 to C30 heteroalkyl group, a substituted or unsubstituted C2 to C30 heterocycloalkyl group, a substituted or unsubstituted C2 to C30 heterocyclic group, a substituted or unsubstituted C2 to C30 alkenyl group, a substituted or unsubstituted C2 to C30 alkynyl group, a hydroxy group, a halogen atom, or a combination thereof. 6. The fused polycyclic heteroaromatic compound of claim 1 , wherein R 3 and R 4 have the same heterocyclic groups. 7. The fused polycyclic heteroaromatic compound of claim 1 , wherein the fused polycyclic heteroaromatic compound is represented by Chemical Formula 4: wherein, in Chemical Formula 4, X 1 , X 2 , Ar, R 1 , and R 2 are the same as in Chemical Formula 1, R 41 to R 44 are independently hydrogen, a substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted C3 to C30 cycloalkyl group, a substituted or unsubstituted C6 to C30 aryl group, a substituted or unsubstituted C7 to C30 arylalkyl group, a substituted or unsubstituted C1 to C30 heteroalkyl group, a substituted or unsubstituted C2 to C30 heterocycloalkyl group, a substituted or unsubstituted C2 to C30 heterocyclic group, a substituted or unsubstituted C2 to C30 alkenyl group, a substituted or unsubstituted C2 to C30 alkynyl group, a hydroxy group, a halogen atom, or a combination thereof, R 41 and R 42 are independently present alone or adjacent two thereof are combined to provide a ring, and R 43 and R 44 are independently present alone or adjacent two thereof are combined to provide a ring. 8. The fused polycyclic heteroaromatic compound of claim 7 , wherein the fused polycyclic heteroaromatic compound is represented by one of Chemical Formula 5-1 to Chemical Formula 5-36: 9. The fused polycyclic heteroaromatic compound of claim 1 , wherein the fused polycyclic heteroaromatic compound is represented by Chemical Formula 6: wherein, in Chemical Formula 6, Ar, R 1 , and R 2 are the same as in Chemical Formula 1, X 61 to X 64 are independently S or Se, R 63 and R 66 are independently a halogen atom, R 61 and R 62 are hydrogen or a substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted C3 to C30 cycloalkyl group, a substituted or unsubstituted C6 to C30 aryl group, a substituted or unsubstituted C7 to C30 arylalkyl group, a substituted or unsubstituted C1 to C30 heteroalkyl group, a substituted or unsubstituted C2 to C30 heterocycloalkyl group, a substituted or unsubstituted C2 to C30 heterocyclic group, a substituted or unsubstitut

Assignees

Inventors

Classifications

  • C07D517/22Primary

    in which the condensed system contains four or more hetero rings · CPC title

  • Organic PV cells · CPC title

  • in which the condensed system contains four or more hetero rings · CPC title

  • Electricity · mapped topic

  • Electricity · mapped topic

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11242357B2 cover?
A fused polycyclic heteroaromatic compound represented by Chemical Formula 1, and an organic thin film, an organic thin film transistor, and an electronic device including the fused polycyclic heteroaromatic compound are provided. The fused polycyclic heteroaromatic compound may have a conjugation structure but reinforce planarity among adjacent rings and have further dense packing and thus muc…
Who is the assignee on this patent?
Samsung Electronics Co Ltd
What technology area does this patent fall under?
Primary CPC classification C07D517/22. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Feb 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).